Chemours (NYSE:CC) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.12 by 8.33 percent. This is a 64.52 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $1.36 billion which met the analyst consensus estimate.